Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia

Details for Australian Patent Application No. 2012203896 (hide)

Owner Syntonix Pharmaceuticals, Inc.

Inventors Rivera, Daniel S.; Peters, Robert T.; Bitonti, Alan J.

Agent Cullens

Pub. Number AU-A-2012203896

Parent 2010201711

Filing date 3 July 2012

Wipo publication date 19 July 2012

International Classifications

C07K 16/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C12N 9/64 Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12P 21/08 Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

19 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203896

19 July 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203897-A gaming system and a method of gaming

2012203895-Barbeque control system